BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10360564)

  • 1. Genentech stands by original data.
    Henner DJ; Goeddel DV; Heyneker H; Itakura K; Yansura D; Ross M; Miozzari G
    Nature; 1999 May; 399(6734):297-8. PubMed ID: 10360564
    [No Abstract]   [Full Text] [Related]  

  • 2. Charges fly in $1bn hormone patent battle.
    Dalton R
    Nature; 1999 May; 399(6734):289. PubMed ID: 10360558
    [No Abstract]   [Full Text] [Related]  

  • 3. UC-Genentech trial.
    Seeburg PH
    Science; 1999 May; 284(5419):1465-6. PubMed ID: 10383323
    [No Abstract]   [Full Text] [Related]  

  • 4. Statement from Peter Seeburg.
    Seeburg PH
    Nature; 1999 May; 399(6734):298. PubMed ID: 10360565
    [No Abstract]   [Full Text] [Related]  

  • 5. Genentech pays $200m over growth hormone 'theft'.
    Dalton R; Schiermeier Q
    Nature; 1999 Nov; 402(6760):335. PubMed ID: 10586857
    [No Abstract]   [Full Text] [Related]  

  • 6. UC-Genentech trial.
    Henner D; Goeddel DV; Heyneker H; Itakura K; Tansura D
    Science; 1999 May; 284(5419):1465. PubMed ID: 10383322
    [No Abstract]   [Full Text] [Related]  

  • 7. Scientific misconduct. Researcher rebuked for 20-year-old misdeed.
    Hagmann M
    Science; 1999 Dec; 286(5448):2249-50. PubMed ID: 10636777
    [No Abstract]   [Full Text] [Related]  

  • 8. A sorry affair.
    Nature; 1999 May; 399(6734):285. PubMed ID: 10360554
    [No Abstract]   [Full Text] [Related]  

  • 9. Affymetrix in new patents row.
    Ledford H
    Nature; 2008 Jul; 454(7203):377. PubMed ID: 18650873
    [No Abstract]   [Full Text] [Related]  

  • 10. Nontraditional publications and their effect on patentable inventions.
    Garabedian TE
    Nat Biotechnol; 2002 Apr; 20(4):401-2. PubMed ID: 11923849
    [No Abstract]   [Full Text] [Related]  

  • 11. US jury split over hormone patent case..
    Dalton R
    Nature; 1999 Jun; 399(6736):512. PubMed ID: 10376586
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality patents.
    Sinclair K
    Australas Biotechnol; 1994; 4(5):284. PubMed ID: 7765675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equivalents in biotechnology patents.
    Auer HE
    Nat Biotechnol; 2003 Mar; 21(3):329-31. PubMed ID: 12610574
    [No Abstract]   [Full Text] [Related]  

  • 14. US acts to lengthen term of patents to help biotechnology.
    Wadman M
    Nature; 1999 Aug; 400(6745):604. PubMed ID: 10458149
    [No Abstract]   [Full Text] [Related]  

  • 15. Need for a court to rule on patents and misconduct.
    Bihain BE
    Nature; 2003 Aug; 424(6951):875. PubMed ID: 12931157
    [No Abstract]   [Full Text] [Related]  

  • 16. Biotechnology patents: strategies for meeting economic and ethical concerns.
    Gold ER
    Nat Genet; 2002 Apr; 30(4):359. PubMed ID: 11925560
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphokine racketeers? Cistron alleges foul play over IL-1, but Immunex sees it differently.
    Hopp TP
    Nat Biotechnol; 1996 Mar; 14(3):275-9. PubMed ID: 9630886
    [No Abstract]   [Full Text] [Related]  

  • 18. Companies balk at California's patent rules for stem cell research.
    Keim B
    Nat Med; 2007 Jan; 13(1):6. PubMed ID: 17206112
    [No Abstract]   [Full Text] [Related]  

  • 19. Patenting biotechnology inventions in China.
    Lui J
    Nat Biotechnol; 2001 Jan; 19(1):83-4. PubMed ID: 11135559
    [No Abstract]   [Full Text] [Related]  

  • 20. Biotech patents and the inequitable conduct doctrine.
    Michael A
    Nat Biotechnol; 2006 Oct; 24(10):1219-21. PubMed ID: 17033655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.